In 2017, the World Health Organization recognized Togo for eliminating lymphatic filariasis as a public problem in the country. Togo is the first country in Africa to receive WHO validation for elimination of the disease.
Togo was validated by the WHO as having eliminated trachoma as a public health problem in May 2022.
Togo stopped OV MDA in the region of Maritimes except in one village in FY22 (October 2021 – September 2022). Five districts will now start implementing post-treatment surveillance.
Togo is one of the first countries to conduct annual community-based mass drug administration (MDA) for soil-transmitted helminths (STH) and schistosomiasis (SCH) at the sub-district level. Togo conducted its second re-assessment survey in 2021 among 93 sub-districts to review the impact of multiple rounds of high coverage MDA.
Togo was the second Act West countries to form a SCH expert committee in 2021.
Togo was one of four countries in West Africa selected by the Task Force for Global Health to conduct a SCH Oversampling survey in three districts in 2022. Togo also conducted its second schistosomiasis/soil-transmitted helminthiasis (SCH/STH) impact survey (the first re-assessment was in 2015) in 10 districts in December 2021. The data from both surveys were discussed at a data review meeting in November 2022 and the country developed a new treatment strategy for 2023. Another 13 districts have been approved to conduct more impact assessments in 2023
Standard Disease-Specific Indicators as of FY21
FY21 is October 2020 through September 2021